Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
24996 | 294 | 25.9 | 24% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
210 | 3 | IMMUNOLOGY//JOURNAL OF INTERFERON RESEARCH//NK CELLS | 51916 |
3092 | 2 | POSTOPERATIVE SEPTIC COMPLICATIONS//TREATMENT RELATED TOXICITIES//MIGRATION STIMULATION FACTOR | 2357 |
24996 | 1 | H LAI TEST//HIGH METASTATIC CAPACITY//IMMUNE TOLERANCEZ | 294 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | H LAI TEST | authKW | 103861 | 0% | 100% | 1 |
2 | HIGH METASTATIC CAPACITY | authKW | 103861 | 0% | 100% | 1 |
3 | IMMUNE TOLERANCEZ | authKW | 103861 | 0% | 100% | 1 |
4 | LEUKOCYTE ADHERENCE INHIBITION TEST | authKW | 103861 | 0% | 100% | 1 |
5 | MED MED MICROBIOL IMMUNOL POB 3926 | address | 103861 | 0% | 100% | 1 |
6 | UKRAINIAN SCI MED GENET | address | 103861 | 0% | 100% | 1 |
7 | LEWIS LUNG TUMOR | authKW | 51930 | 0% | 50% | 1 |
8 | LEUKOCYTE ADHERENCE INHIBITION ASSAY | authKW | 34619 | 0% | 33% | 1 |
9 | TUMORDIAGNOSTIK | journal | 34613 | 1% | 8% | 4 |
10 | ARCHIV FUR GESCHWULSTFORSCHUNG | journal | 22476 | 3% | 2% | 9 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 3162 | 53% | 0% | 157 |
2 | Immunology | 747 | 25% | 0% | 74 |
3 | Medicine, Research & Experimental | 33 | 5% | 0% | 15 |
4 | Cell Biology | 18 | 6% | 0% | 18 |
5 | Urology & Nephrology | 9 | 2% | 0% | 7 |
6 | Surgery | 7 | 5% | 0% | 15 |
7 | Dermatology | 7 | 2% | 0% | 5 |
8 | Mycology | 5 | 1% | 0% | 2 |
9 | Medicine, General & Internal | 2 | 3% | 0% | 9 |
10 | Medical Laboratory Technology | 2 | 1% | 0% | 2 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MED MED MICROBIOL IMMUNOL POB 3926 | 103861 | 0% | 100% | 1 |
2 | UKRAINIAN SCI MED GENET | 103861 | 0% | 100% | 1 |
3 | CENT TUMORS ALLIED DIS | 20771 | 0% | 20% | 1 |
4 | IMMUNOL EXPT ALLERGY | 17309 | 0% | 17% | 1 |
5 | RUTH BEN ARI CLIN IMMUNOL | 10384 | 0% | 10% | 1 |
6 | CHEM IMMUNOL | 705 | 0% | 1% | 1 |
7 | RE KAVETSKY EXPT PATHOL ONCOL RADIOBIOL | 545 | 0% | 1% | 1 |
8 | PEDIAT OBSTET GYNECOL | 370 | 0% | 0% | 1 |
9 | BIOMATH | 37 | 0% | 0% | 1 |
10 | GASTROENTEROL UNIT | 25 | 0% | 0% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TUMORDIAGNOSTIK | 34613 | 1% | 8% | 4 |
2 | ARCHIV FUR GESCHWULSTFORSCHUNG | 22476 | 3% | 2% | 9 |
3 | VOPROSY ONKOLOGII | 6672 | 3% | 1% | 10 |
4 | EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 6663 | 4% | 1% | 11 |
5 | JOURNAL OF THE NATIONAL CANCER INSTITUTE | 6125 | 6% | 0% | 17 |
6 | AUSTRALIAN JOURNAL OF EXPERIMENTAL BIOLOGY AND MEDICAL SCIENCE | 5456 | 2% | 1% | 5 |
7 | IMMUNOLOGICAL COMMUNICATIONS | 4302 | 1% | 1% | 3 |
8 | NEOPLASMA | 4044 | 4% | 0% | 11 |
9 | TUMORDIAGNOSTIK & THERAPIE | 3332 | 2% | 1% | 5 |
10 | ONCOLOGY | 3185 | 4% | 0% | 11 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LABATEYA, N , THOMSON, DMP , REID, EC , (1986) LEUKOCYTE ACTIVATION IN ADVANCED CANCER AS AN EXPLANATION FOR ABSENT LEUKOCYTE ADHERENCE INHIBITION TO CANCER EXTRACTS AND CHEMOATTRACTANT.EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY. VOL. 22. ISSUE 1. P. 33-43 | 29 | 76% | 1 |
2 | KUBASOVA, T , HORVATH, M , SZARVAS, I , BEKE, CS , KOTELES, GJ , (1989) MODIFIED HUMORAL LEUKOCYTE ADHERENCE INHIBITION TEST FOR DETECTION OF LUNG-CANCER.ONCOLOGY. VOL. 46. ISSUE 6. P. 386-390 | 15 | 100% | 0 |
3 | GOUDA, Z , THOMSON, DMP , (1988) MEASUREMENT BY LEUKOCYTE ADHERENCE INHIBITION OF AUTOSENSITIZATION OF CANCER-PATIENTS TO MYELIN BASIC-PROTEIN.JAPANESE JOURNAL OF CANCER RESEARCH. VOL. 79. ISSUE 4. P. 529-537 | 24 | 55% | 1 |
4 | KOTLAR, HK , SANNER, T , (1988) ROLE OF LYMPHOCYTES-T IN PRODUCTION OF A CANCER-ASSOCIATED PROTEIN FACTOR IN SERUM FROM LUNG-CANCER PATIENTS.EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY. VOL. 24. ISSUE 11. P. 1763-1770 | 16 | 80% | 1 |
5 | THOMSON, DMP , SPRINGER, GF , DESAI, PR , SCANZANO, R , GUBERSKY, M , SHENOUDA, G , (1988) COMPARISON BY LEUKOCYTE ADHERENCE INHIBITION OF HUMAN IMMUNE-RESPONSE TO CANCER-ASSOCIATED IMMUNOGENS, THOMSEN-FRIEDENREICH (T) AND TN, MYELIN BASIC-PROTEIN, AND ORGAN-SPECIFIC CANCER NEOANTIGENS.CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY. VOL. 49. ISSUE 2. P. 231-241 | 19 | 66% | 2 |
6 | LABATEYA, N , THOMSON, DMP , DURKO, M , SHENOUDA, G , ROBB, L , SCANZANO, R , (1987) EXTRACTION OF HUMAN ORGAN-SPECIFIC CANCER NEOANTIGENS FROM CANCER-CELLS AND PLASMA-MEMBRANES WITH 1-BUTANOL.CANCER RESEARCH. VOL. 47. ISSUE 4. P. 1058-1064 | 20 | 48% | 8 |
7 | HARDING, MW , YANG, TJ , (1985) REGULATION OF LEUKOCYTE GLASS ADHERENCE AND TUBE LEUKOCYTE ADHERENCE INHIBITION (LAI) REACTIVITY BY SERUM FACTORS IN DOGS WITH PROGRESSING OR SPONTANEOUSLY REGRESSING CANINE TRANSMISSIBLE VENEREAL SARCOMA (CTVS).CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 19. ISSUE 3. P. 168-176 | 13 | 81% | 0 |
8 | DUBOIS, AEJ , THOMSON, DMP , SUTHERLAND, ME , SCANZANO, R , (1985) AN ISOLATED ENRICHED ORGAN-SPECIFIC CANCER NEOANTIGEN OF HUMAN-LUNG CANCER FOR LEUKOCYTE ADHERENCE INHIBITION ASSAYS.CANCER RESEARCH. VOL. 45. ISSUE 6. P. 2661-2669 | 15 | 68% | 3 |
9 | ARTIGAS, C , THOMSON, DMP , DURKO, M , SUTHERLAND, M , SCANZANO, R , SHENOUDA, G , DUBOIS, AEJ , (1986) IDENTIFICATION OF A MR40,000 POLYPEPTIDE FROM COLORECTAL-CANCER WHICH EXPRESSES ORGAN-SPECIFIC CANCER NEOANTIGEN ACTIVITY AS DETERMINED BY LEUKOCYTE ADHERENCE INHIBITION.CANCER RESEARCH. VOL. 46. ISSUE 4. P. 1874-1881 | 15 | 63% | 10 |
10 | THOMSON, DMP , SUTHERLAND, M , SCANZANO, R , SHENOUDA, G , (1987) RECOGNITION OF A PURIFIED MR-40,000 ORGAN-SPECIFIC IMMUNOGEN OF HUMAN-LUNG CANCER BY CLASS-II-RESTRICTED T-CELLS.JOURNAL OF THE NATIONAL CANCER INSTITUTE. VOL. 79. ISSUE 4. P. 653-661 | 20 | 43% | 2 |
Classes with closest relation at Level 1 |